Interferon and 2-5A synthetase in patients with immune diseases.
Preble
O T
OT
Yeh
T J
TJ
Silverman
R H
RH
Klippel
J H
JH
Straus
S E
SE
Gelmann
E P
EP
D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood*; D000163:Acquired Immunodeficiency Syndrome / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D004854:Herpesvirus 4, Human; D006801:Humans; D007154:Immune System Diseases / Q000201:enzymology / Q000276:immunology / Q000628:therapy*; D007244:Infectious Mononucleosis / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D007370:Interferon Type I / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000201:enzymology / Q000276:immunology / Q000628:therapy; D008297:Male
D007370:Interferon Type I; D007372:Interferons; D015088:2',5'-Oligoadenylate Synthetase